Tuberculosis Clinical Trial
Official title:
A Knowledge Translation Intervention for TB/HIV Treatment Adherence, in Zomba District, Malawi
Despite increased emphasis on evidence based practice in recent years a gap remains between
evidence and practice, particularly in resource poor countries. Few studies to date have
examined the use of knowledge translation strategies to improve health care outcomes in low
income countries. However, given that the majority of health care in these settings is
provided by workers with less training and limited resources, the theoretical potential for
knowledge translation strategies to improve health care delivery and outcomes by integrating
best evidence into routine practice may be greatest in these settings.
Knowledge translation (KT) is an approach to changing health care provider behavior to
reduce the gap between evidence and practice in health care delivery. There has been a
tendency for knowledge translation interventions to employ generic, "off the shelf",
strategies, and apply them to deal with specific issues. This generic approach, fails to
recognize the variability in the specific characteristics of health care settings, in terms
of their patient populations, health care systems, and health care providers. These
characteristics, whether they function as barriers or facilitators to change, make a
generalized approach to KT ineffective, where a tailored strategy, which specifically
adjusts its approach to measured local barriers and facilitators may achieve better
alignment of practice to evidence. This is likely to be particularly true in low income
countries where the majority of health care is provided by non-physician health care
workers, working within a wider range of health care systems, with variable and unique
patient populations and resource constraints. Given the potential to significantly impact
health care outcomes at relatively low cost, further research is needed both to develop
methods for identifying potential barriers and facilitators to KT strategies in specific
resource poor settings, and to evaluate the effectiveness of KT strategies tailored to
address the identified barriers.
This study will assess the effectiveness of a two part knowledge translation intervention
tailored to address factors identified in a previous study as functioning as barriers and
facilitators to treatment adherence among patients on treatment for tuberculosis or combined
tuberculosis and antiretroviral treatment, targeting improved patient adherence and health
outcomes, in a specific low income country.
n/a
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Health Services Research
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05738681 -
Efficacy of N-acetylcysteine to Prevent Anti-tuberculosis Drug-induced Liver Injury: A Randomized Controlled Trial
|
Phase 2/Phase 3 | |
Recruiting |
NCT05526885 -
Tuberculosis Diagnostic Trial of CAD4TB Screening Alone Compared to CAD4TB Screening Combined With a CRP Triage Test, Both Followed by Confirmatory Xpert MTB/RIF Ultra in Communities of Lesotho and South Africa
|
N/A | |
Completed |
NCT04369326 -
Community Initiated Preventive Therapy for TB
|
N/A | |
Recruiting |
NCT04568967 -
TB-CAPT EXULTANT - HIV
|
N/A | |
Completed |
NCT02337270 -
Phase 1 Clinical Trial of the Safety and Immunogenicity of an Adenovirus-based TB Vaccine Administered by Aerosol
|
Phase 1 | |
Not yet recruiting |
NCT06253715 -
Shortened Regimen for Drug-susceptible TB in Children
|
Phase 3 | |
Recruiting |
NCT04271397 -
Immunological Biomarkers in Tuberculosis Management
|
N/A | |
Withdrawn |
NCT03639038 -
Tuberculosis Diagnosis by Flow Cytometry
|
||
Completed |
NCT03199313 -
Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Sutezolid
|
Phase 1 | |
Recruiting |
NCT04975178 -
Efficacy, Safety and Immunogenicity Evaluation of MTBVAC in Newborns in Sub-Saharan Africa
|
Phase 3 | |
Completed |
NCT04463680 -
Rifampin and the Contraceptive Implant
|
Phase 4 | |
Completed |
NCT03973970 -
Assessing the Ability of the T-SPOT®.TB Test (IQ)
|
||
Recruiting |
NCT04230395 -
Alcohol Reduction Among People With TB and HIV in India
|
N/A | |
Completed |
NCT04874948 -
Absorption, Elimination and Safety of 14C-labeled Radioactive BTZ-043, a New Compound in TB Treatment
|
Phase 1 | |
Active, not recruiting |
NCT02906007 -
Evaluating the Pharmacokinetics, Safety, and Tolerability of Bedaquiline in Infants, Children, and Adolescents With Multidrug-Resistant Tuberculosis, Living With or Without HIV
|
Phase 1/Phase 2 | |
Not yet recruiting |
NCT05917210 -
Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda
|
N/A | |
Not yet recruiting |
NCT05845112 -
Start Taking Action For TB Diagnosis
|
||
Not yet recruiting |
NCT06017843 -
Impact Evaluation of Use of MATCH AI Predictive Modelling for Identification of Hotspots for TB Active Case Finding
|
N/A | |
Active, not recruiting |
NCT02715271 -
Study of TB Lesions Obtained in Therapeutical Surgery
|
||
Completed |
NCT02781909 -
Potential Efficacy and Safety of Using Adjunctive Ibuprofen for XDR-TB Tuberculosis
|
Phase 2 |